Wellcome Trust-funded stem cell research has produced red blood cells fit for transfusion into humans, paving the way for the mass production of blood
It is the stuff of gothic science fiction: men in white coats in factories of blood and bones.
But the production of blood on an industrial scale could become a reality once a trial is conducted in which artificial blood made from human stem cells is tested in patients for the first time.
It is the latest breakthrough in scientists’ efforts to re-engineer the body, which have already resulted in the likes of 3d-printed bones and bionic limbs.
Marc Turner, the principal researcher in the £5 million programme funded by the Wellcome Trust, told The Telegraph that his team had made red blood cells fit for clinical transfusion.
Prof Turner has devised a technique to culture red blood cells from induced pluripotent stem (iPS) cells – cells that have been taken from humans and ‘rewound’ into stem cells. Biochemical conditions similar to those in the human body are then recreated to induce the iPS cells to mature into red blood cells – of the rare universal blood type O-.
“Although similar research has been conducted elsewhere, this is the first time anybody has manufactured blood to the appropriate quality and safety standards for transfusion into a human being,” said Prof Turner.
There are plans in place for the trial to be concluded by late 2016 or early 2017, he said. It will most likely involve the treatment of three patients with Thalassaemia, a blood disorder requiring regular transfusions. The behaviour of the manufactured blood cells will then be monitored.
“The cells will be safe,” he said, adding that there are processes whereby cells can be removed.
The technique highlights the prospect of a limitless supply of manufactured type O- blood, free of disease and compatible with all patients.
The Latest on: Artificial blood
via Google News
The Latest on: Artificial blood
- Global Synthetic Blood Vessels Market to Exhibit CAGR of 5.7% through 2026 as Cardiovascular Diseases Remain Highon December 8, 2021 at 8:00 am
The global synthetic artificial blood vessels market is poised to witness a great stake in the healthcare industry as the number of cardiovascular and peripheral vascular cases continue to grow.
- Artificial Intelligence Model can Predict Disease Progression During Agingon December 8, 2021 at 3:43 am
New computer model developed can help assess long-term chronic drug therapies and help clinicians develop more effective treatments for complex diseases.
- AI-based technology to identify patients at risk of serious illness as a result of blood infectionson December 7, 2021 at 10:33 pm
A new technology developed at Tel Aviv University will make it possible, using artificial intelligence, to identify patients who are at risk of serious illness as a result of blood infections.
- Medical AI, made in Israel, prevents blood infection deathson December 7, 2021 at 9:50 pm
Artificial intelligence technology, developed in Israel, is saving lives by informing medical professionals which patients are the most at-risk in the event of a blood infection. By feeding medical ...
- ‘Life saving’ Israeli tech helps ID patients most at risk from blood infectionson December 7, 2021 at 7:20 pm
Blood infections are common, with 250,000 annually in the US; Tel Aviv artificial intelligence allows doctors to focus attention on those with high risk of death or serious illness ...
- Flagship Pioneering Launches Harbinger Health to Detect Early Cancer with a Simple, Bio-AI Based Blood Teston December 7, 2021 at 3:43 am
Flagship Pioneering today announced the launch of Harbinger Health, a bioplatform company pioneering the detection of early cancer with a simple blood test that combines Artificial Intelligence (AI) ...
- Saving lives with artificial intelligenceon December 7, 2021 at 2:49 am
New technology developed at Tel Aviv University uses artificial intelligence to help doctors identify high-risk patients.
- Your Healthy Family: How an artificial lung helps patients with severe COVID-19 recoveron December 7, 2021 at 2:37 am
Patients who come down with a severe case of COVID-19, are sometimes put on a ventilator so they can get the oxygen they need to survive. But sometimes that's not enough, and some patients are put on ...
- Artificial sweetener may be cause of digestive issueon December 7, 2021 at 1:30 am
Q: I bought some diet jellybeans that used sucralose as the artificial sweetener. After eating a bunch of them I developed lots of gas and diarrhea that I think may have been from the jellybeans. Is ...
- Israeli Scientists Develop Tech to Save Lives with Artificial Intelligenceon December 6, 2021 at 12:26 pm
A new technology developed at Tel Aviv University will make it possible, using artificial intelligence, to identify patients who are at risk of serious illness as a result of blood infections.The ...
via Bing News